Chyu, A.; Xi, S.; Kim, J.; Liu, G.; Chan, I.; Hong, S.; Ke, A.; Lavery, T.; Marimuthu, A.; Akula, A.;
et al. Benchtop 19F Nuclear Magnetic Resonance (NMR) Spectroscopy-Optimized Knorr Pyrazole Synthesis of Celecoxib and Mavacoxib, 3-(Trifluoromethyl) Pyrazolyl Benzenesulfonamides, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Spectrosc. J. 2024, 2, 206-215.
https://doi.org/10.3390/spectroscj2040014
AMA Style
Chyu A, Xi S, Kim J, Liu G, Chan I, Hong S, Ke A, Lavery T, Marimuthu A, Akula A,
et al. Benchtop 19F Nuclear Magnetic Resonance (NMR) Spectroscopy-Optimized Knorr Pyrazole Synthesis of Celecoxib and Mavacoxib, 3-(Trifluoromethyl) Pyrazolyl Benzenesulfonamides, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Spectroscopy Journal. 2024; 2(4):206-215.
https://doi.org/10.3390/spectroscj2040014
Chicago/Turabian Style
Chyu, Andrew, Selina Xi, Joshua Kim, Galen Liu, Indalina Chan, Seoyeon Hong, Allen Ke, Thomas Lavery, Anushree Marimuthu, Arjun Akula,
and et al. 2024. "Benchtop 19F Nuclear Magnetic Resonance (NMR) Spectroscopy-Optimized Knorr Pyrazole Synthesis of Celecoxib and Mavacoxib, 3-(Trifluoromethyl) Pyrazolyl Benzenesulfonamides, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)" Spectroscopy Journal 2, no. 4: 206-215.
https://doi.org/10.3390/spectroscj2040014
APA Style
Chyu, A., Xi, S., Kim, J., Liu, G., Chan, I., Hong, S., Ke, A., Lavery, T., Marimuthu, A., Akula, A., & Njoo, E.
(2024). Benchtop 19F Nuclear Magnetic Resonance (NMR) Spectroscopy-Optimized Knorr Pyrazole Synthesis of Celecoxib and Mavacoxib, 3-(Trifluoromethyl) Pyrazolyl Benzenesulfonamides, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Spectroscopy Journal, 2(4), 206-215.
https://doi.org/10.3390/spectroscj2040014
